Paper Details

  1. Home
  2. Paper Details

Tics in Tourette syndrome: new treatment options.

Author: AwaadY

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Baclofen and botulinum toxin type A may be effective and safe treatments for Tourette's syndrome, offering an alternative to medications with significant side effects. Further studies are needed to confirm these findings.
Paper Details　
Original Abstract of the Article :
Tourette Syndrome is a familial neurobehavioral disorder characterized by fluctuating involuntary motor and/or vocal tics. The most commonly used medications to treat Tourette's syndrome are haloperidol, pimozide, fluphenazine, and clonidine, all of which may have considerable side effects. We enrol...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/088307389901400508

データ提供：米国国立医学図書館（NLM）

New Treatment Options for Tics in Tourette Syndrome

This study explores the use of baclofen and botulinum toxin type A for treating tics in Tourette syndrome. Researchers investigated the effectiveness and safety of these treatments in a group of 450 patients with tics/Tourette’s syndrome.

Baclofen and Botulinum Toxin Show Promise for Treating Tics

The study found that baclofen and botulinum toxin type A were very effective, safe, and reliable in treating tics/Tourette's syndrome. This research suggests that these treatments may offer a valuable alternative to conventional medications, which often have significant side effects.

Potential for Improved Treatment of Tourette Syndrome

The study's findings provide encouraging evidence for the potential of baclofen and botulinum toxin type A to improve the treatment of Tourette syndrome. Further research is needed to optimize treatment protocols and explore the long-term benefits of these therapies. This research opens up a new frontier for managing Tourette syndrome, offering hope for individuals seeking effective and safe treatment options.

Dr.Camel's Conclusion

This study presents promising evidence for the use of baclofen and botulinum toxin type A in treating tics in Tourette syndrome. The study's findings suggest that these therapies may provide a valuable alternative to conventional medications with fewer side effects. It’s like discovering a new oasis of relief in the desert of Tourette syndrome, offering hope for patients seeking effective treatment options.

Date :
  1. Date Completed 1999-09-23
  2. Date Revised 2021-04-02
Further Info :

Pubmed ID

10342599

DOI: Digital Object Identifier

10.1177/088307389901400508

Related Literature

Article Analysis
・Side Effects of pimozide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.